Who is sponsoring NCT03507192?

NCT03507192 is sponsored by Samsung Medical Center.

What drugs are being tested in NCT03507192?

Interventions in NCT03507192: Muscle relaxation using full body massage machine.

What condition does NCT03507192 study?

NCT03507192 studies Mild Cognitive Impairment, Alzheimer Dementia.

Is NCT03507192 still recruiting?

NCT03507192 is currently status unknown. Last updated 14 March 2019.

Last reviewed 2019-03-14 · How we verify

NCT03507192

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia.

Status unknown NA Last updated 14 March 2019

What this trial tests

NA trial testing Muscle relaxation using full body massage machine in Mild Cognitive Impairment in 60 participants. Status unknown.

Timeline

25 September 2017

Primary endpoint
31 December 2019

31 December 2019

Quick facts

Lead sponsor	Samsung Medical Center
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	60
Start date	25 September 2017
Primary completion	31 December 2019
Estimated completion	31 December 2019
Sites	1 location across South Korea

Drugs / interventions tested

Muscle relaxation using full body massage machine

Conditions studied

Mild Cognitive Impairment — all drugs for Mild Cognitive Impairment →
Alzheimer Dementia — all drugs for Alzheimer Dementia →

Sponsor

Samsung Medical Center

Who can join

Adults 50 to 85, any sex, with Mild Cognitive Impairment or Alzheimer Dementia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Muscle relaxation has been reported to be effective in alleviating anxiety and agitation symptoms in patients with dementia, but no studies have examined the effects of muscle relaxation therapy on cognitive function changes. Therefore, the purpose of this study is to compare and validate the improvement of cognitive function in patients with mild cognitive impairment and early alzheimer's dementia aged 50 to 85 years after performing muscle relaxation machine massage regularly.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effects of Electrical Automatic Massage on Cognition and Sleep Quality in Alzheimer's Disease Spectrum Patients: A Randomized Controlled Trial.
Kim YJ, Kim HR, Jung YH, Park YH, et al · · 2021 · cited 5× · PMID 34296549 · DOI 10.3349/ymj.2021.62.8.717

Verify or expand the search:

Other recruiting trials for Mild Cognitive Impairment

Currently open trials in the same condition.

NCT05791994 — EVASION: Effect of VisuAl Stimulation on attentION · NA · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07220694 — Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairmen · NA · recruiting
NCT06983769 — CPAP vs MAD for OSA in Patients With Cognitive Impairment. A Randomized Clinical Trial · NA · recruiting
NCT07318038 — The Use of Rhythmic Light Therapy in Mild Cognitive Impairment · NA · recruiting

Other Samsung Medical Center trials

Trials by the same sponsor.

NCT07482865 — Routine Versus Provisional Distal Perfusion Catheter Placement in Patients Undergoing Mechanical Circulatory Support · NA · not yet recruiting
NCT07467213 — Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute M · Phase 4 · not yet recruiting
NCT07530913 — Effectiveness Analysis of a Rehabilitation Exercise Platform for Living Donor Liver Transplantation Patients · NA · enrolling by invitation
NCT07500701 — Salvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After Radical Pro · Phase 3 · recruiting
NCT07409441 — Korea Acute Myocardial Infarction Registry · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03507192 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Samsung Medical Center
Last refreshed: 14 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03507192.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing